Crossmark

Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission

Crossref DOI link: https://doi.org/10.1186/s41927-021-00196-1

Published Online: 2021-08-04

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rinkin, Charline https://orcid.org/0000-0003-2243-6799
Fosse, Pacôme https://orcid.org/0000-0003-1659-1418
Malaise, Olivier https://orcid.org/0000-0002-2799-2949
Chapelier, Nathalie https://orcid.org/0000-0002-3480-1610
Horrion, Jil https://orcid.org/0000-0001-8161-2938
Seidel, Laurence https://orcid.org/0000-0003-2733-269X
Albert, Adelin https://orcid.org/0000-0003-3844-3774
Hustinx, Roland https://orcid.org/0000-0001-7164-8742
Malaise, Michel G. https://orcid.org/0000-0002-0132-2867
License Information

Text and Data Mining valid from 2021-08-04

Version of Record valid from 2021-08-04
More Information

Article History

Received: 13 August 2020

Accepted: 28 April 2021

First Online: 4 August 2021

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the ethical committee of the university hospital of Liège (B70720108722). Written informed consent was obtained from all individual participants included in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below